Your session is about to expire
← Back to Search
Tobacco Marketplace Study for Cigarette Smoking
N/A
Waitlist Available
Led By Amanda Quisenberry
Research Sponsored by Roswell Park Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of the session , assessed up to 15 months
Awards & highlights
Study Summary
This trial uses an Experimental Tobacco Marketplace to study the purchase of tobacco products in menthol cigarette smokers. A greater understanding of tobacco product purchasing could help inform possible regulatory actions by the Food and Drug Administration.
Who is the study for?
This trial is for adult menthol cigarette smokers who smoke a brand with a non-menthol version and live in Western New York. It's not for those under 18, pregnant women, prisoners, or anyone unable to consent. People with certain eye conditions like macular degeneration or glaucoma can't join.Check my eligibility
What is being tested?
The study uses an Experimental Tobacco Marketplace to see how menthol cigarette smokers buy tobacco products when given options including flavored and unflavored e-cigarettes. The goal is to understand if banning flavors might lead to quitting smoking or less harm.See study design
What are the potential side effects?
Since this trial involves assessments and questionnaires rather than medical treatments, there are no direct side effects from interventions. However, participants may experience discomfort discussing their smoking habits.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am unable to give consent for myself.
Select...
I am under the age of 18.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of the session , assessed up to 15 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of the session , assessed up to 15 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cessation of Menthol flavored cigarettes
Eye tracking metrics
Trial Design
1Treatment groups
Experimental Treatment
Group I: PreventionExperimental Treatment3 Interventions
During the session, participants are presented with randomly ordered conditions: menthol cigarettes and five flavored e-cigarettes (menthol/mint, fruits, sweets, alcohol, snacks/meals), menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes, non-menthol cigarettes and five flavored e-cigarettes, and non-menthol cigarettes and both unflavored and tobacco-flavored e-cigarettes. Participants' visual attention is evaluated by eye-tracking equipment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention
2005
N/A
~1800
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,211 Total Patients Enrolled
Roswell Park Cancer InstituteLead Sponsor
404 Previous Clinical Trials
31,198 Total Patients Enrolled
Amanda QuisenberryPrincipal InvestigatorRoswell Park Cancer Institute
1 Previous Clinical Trials
20 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am unable to give consent for myself.I have a history of eye conditions or use visual aids like screen readers.I am under the age of 18.You are pregnant.I smoke menthol cigarettes that have a non-menthol version.You live in Western New York.
Research Study Groups:
This trial has the following groups:- Group 1: Prevention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger